Europe Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

  • Product Code:
    RP-ID-10346708
  • Published Date:
    5 Jan 2021
  • Region:
    Global
  • Pages:
    113
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-26

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Europe pharmaceutical CRO market accounted for $11.96 billion in 2019 and will grow by 7.9% annually over 2020-2030 owing to the rising incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 36 tables and 45 figures, this 113-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe pharmaceutical CRO market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK Europe Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Europe Market by Service 41
3.1 Market Overview by Service 41
3.2 CRO for Pre-clinical Development 43
3.3 CRO for Phase I Trials 44
3.4 CRO for Phase II Trials 45
3.5 CRO for Phase III Trials 46
3.6 CRO for Phase IV Trials 47
3.7 Laboratory Services 48
3.8 Consulting Services 49
3.9 Data Management Services 50
4 Segmentation of Europe Market by Therapeutic Application 51
4.1 Market Overview by Therapeutic Application 51
4.2 Infectious Diseases 53
4.3 Oncology 54
4.4 Metabolic Disorders 55
4.5 Cardiovascular Disorders 56
4.6 Central Nervous System 57
4.7 Respiratory Disorders 58
4.8 Gastrointestinal Disorders 59
4.9 Other Therapeutic Applications 60
5 Segmentation of Europe Market by End User 61
5.1 Market Overview by End User 61
5.2 Pharmaceutical & Biopharmaceutical Companies 63
5.3 Medical Device Companies 64
5.4 Academic Institutes 65
6 European Market 2019-2030 by Country 67
6.1 Overview of European Market 67
6.2 Germany 70
6.3 UK 72
6.4 France 75
6.5 Spain 77
6.6 Italy 79
6.7 Russia 81
6.8 Rest of European Market 83
7 Competitive Landscape 85
7.1 Overview of Key Vendors 85
7.2 New Product Launch, Partnership, Investment, and M&A 89
7.3 Company Profiles 90
Charles River Laboratories 90
CMIC Co. Ltd 92
Covance Inc. 93
Hangzhou Tigermed Consulting Co Ltd 94
ICON Plc 95
IQVIA Holdings Inc. 96
LSK Europe Pharma Service Co Ltd 97
Novotech Pty Ltd 98
PAREXEL International Corporation 99
Pharmaceutical Product Development LLC (PPD) 100
PRA Health Sciences Inc. 101
Quanticate Ltd 102
Samsung Bioepis Co. Ltd 103
SGS SA (SGS Life Sciences) 104
Syneos Health Inc. 105
WuXi AppTec Inc. 106
8 Investing in Europe Market: Risk Assessment and Management 107
8.1 Risk Evaluation of Europe Market 107
8.2 Critical Success Factors (CSFs) 110
Related Reports and Products 113Table 1. Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World Real GDP, 2017-2021 21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. Worldwide Total Number of Registered Clinical Trials 29
Table 5. Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market 33
Table 6. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn 41
Table 7. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 51
Table 8. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn 61
Table 9. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn 69
Table 10. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn 71
Table 11. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 71
Table 12. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn 71
Table 13. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn 74
Table 14. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 74
Table 15. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn 74
Table 16. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn 76
Table 17. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 76
Table 18. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn 76
Table 19. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn 78
Table 20. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 78
Table 21. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn 78
Table 22. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn 80
Table 23. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 80
Table 24. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn 80
Table 25. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 82
Table 26. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 82
Table 27. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 82
Table 28. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn 84
Table 29. Breakdown of Europe Market by Key Vendor, 2019, % 87
Table 30. Charles River Laboratories: Company Snapshot 90
Table 31. Charles River Laboratories: Business Segmentation 90
Table 32. Charles River Laboratories: Product Portfolio 91
Table 33. Charles River Laboratories: Revenue, 2016-2018, $ bn 91
Table 34. Charles River Laboratories: Recent Developments 91
Table 35. Risk Evaluation for Investing in Europe Market, 2019-2030 108
Table 36. Critical Success Factors and Key Takeaways 111Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn 19
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market 25
Figure 8. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market 30
Figure 9. Investment Opportunity Analysis 34
Figure 10. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market 37
Figure 11. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 42
Figure 12. Europe Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%) 42
Figure 13. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 43
Figure 14. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 44
Figure 15. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 45
Figure 16. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 46
Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 47
Figure 18. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 48
Figure 19. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 49
Figure 20. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 50
Figure 21. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 52
Figure 22. Europe Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%) 52
Figure 23. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 53
Figure 24. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 54
Figure 25. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 55
Figure 26. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 56
Figure 27. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 57
Figure 28. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 58
Figure 29. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 59
Figure 30. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 60
Figure 31. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 62
Figure 32. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%) 62
Figure 33. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 63
Figure 34. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 64
Figure 35. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 65
Figure 36. Breakdown of European Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue 68
Figure 37. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 69
Figure 38. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn 70
Figure 39. Pharmaceutical CRO Market in UK, 2019-2030, $ bn 72
Figure 40. Pharmaceutical CRO Market in France, 2019-2030, $ bn 75
Figure 41. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn 77
Figure 42. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn 79
Figure 43. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn 81
Figure 44. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn 83
Figure 45. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period 85
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Key Players (this may not be a complete list and extra companies can be added upon request):
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co Ltd
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co Ltd
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co. Ltd
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports